$ISIS Recent News Strong bull trend absorbs Fed-induced

New Post Public Reply Private Reply Replies (0) Message Board

Nov 16, 2014 at 12:23 PM

$ISIS Recent News

Strong bull trend absorbs Fed-induced whipsaw 9:59 a.m. Oct. 30, 2014 - Michael Ashbaugh
This tiny biotech company takes the real ice bucket challenge 9:14 a.m. Sept. 2, 2014 - Michael Brush
A lesson in buying low in a high group 11:01 p.m. Sept. 1, 2014 - Michael Kahn
5 companies that will benefit from ALS awareness 6:58 a.m. Aug. 22, 2014 - Jennifer Booton
Investors blow on the dice as Iraq and the Fed shake up markets 8:09 a.m. June 16, 2014 - Shawn Langlois
S&P, Dow pull in from latest record highs 10:10 a.m. June 2, 2014 - Michael Ashbaugh
Health-care-related stocks keep on giving 12:02 p.m. Feb. 12, 2014 - The Trading Deck
See the future 12:42 p.m. Feb. 3, 2014 - Cody Willard
Charting the S&P 500’s excellent 2013 adventure 11:59 a.m. Dec. 23, 2013 - Michael Ashbaugh
Market technicals tame despite debt-ceiling debate 10:43 a.m. Sept. 25, 2013 - Michael Ashbaugh
Isis reaches a new high on tests for treatment of muscular disorder 2:03 p.m. Sept. 19, 2013 - Russ Britt
Isis, Biogen working on ways to fight disease through gene altering 9:59 a.m. Sept. 9, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 10:48 a.m. Sept. 3, 2013 - Russ Britt
Despite positive tests, investors let some air out of Isis Pharmaceuticals 10:30 a.m. July 22, 2013 - Russ Britt
5 stocks to watch 2:35 p.m. July 11, 2013 - The Trading Deck
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
S&P’s 50-day average marks the technical test 10:39 a.m. June 27, 2013 - Michael Ashbaugh
After the close: Alexion climbs on FDA news, Biogen basks in glory 4:35 p.m. June 26, 2013 - Russ Britt
After dramatic moves, Isis and Allergan dart in different directions 5:18 p.m. June 25, 2013 - Russ Britt
Dissecting the close: Isis soars on data, while Pfizer loses on spin-off 6:26 p.m. June 24, 2013 - Russ Britt

Isis/AstraZeneca Expand Antisense Technology Collaboration - Analyst Blog 4:30 p.m. Nov. 14, 2014 - Zacks.com
Cramer's Lightning Round - VeriFone Is Going To Have A Big Year (11/12/14) 9:05 a.m. Nov. 13, 2014 - Seeking Alpha
'Mad Money' Lightning Round: VeriFone Is Integral to ApplePlay 6:00 a.m. Nov. 13, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – ARNA ISIS ACAD PBYI 5:45 a.m. Nov. 13, 2014 - InvestorPlace.com
Jim Cramer's 'Mad Money' Recap: Pining for Quiet Stock That Climbs 8:57 p.m. Nov. 12, 2014 - TheStreet.com
Isis Pharmaceuticals (ISIS) Highlighted As Today's Perilous Reversal Stock 9:48 a.m. Nov. 12, 2014 - TheStreet.com
Cramer's Mad Money - The Hottest Stock You've Never Heard Of (11/11/14) 5:20 a.m. Nov. 12, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Pile Into Housing, Biotech and Pop Cult Names 8:59 p.m. Nov. 11, 2014 - TheStreet.com
One Reason Isis Pharmaceuticals (ISIS) Stock Is Gaining Today 11:24 a.m. Nov. 11, 2014 - TheStreet.com
Isis Pharmaceuticals (ISIS) Is Strong On High Volume Today 10:02 a.m. Nov. 11, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – ICUI ISIS NPSP PDLI 6:30 a.m. Nov. 11, 2014 - InvestorPlace.com
ISIS Pharmaceuticals' (ISIS) CEO Stan Crooke on Q3 2014 Results - Earnings Call Transcript 6:52 p.m. Nov. 7, 2014 - Seeking Alpha
Will Isis Pharmaceuticals (ISIS) Disappoint on Q3 Earnings? - Analyst Blog 6:00 p.m. Nov. 5, 2014 - Zacks.com
Cramer Sees HP Entering Sector as Trouble for 3-D Printing Stocks 11:57 a.m. Nov. 3, 2014 - TheStreet.com
Isis Pharmaceuticals, Inc. (ISIS): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Oct. 30, 2014 - Zacks.com
Cramer's Lightning Round: Isis Is Still Good (10/29/14) 7:43 a.m. Oct. 30, 2014 - Seeking Alpha
'Mad Money' Lightning Round: Stay Away From Applied Materials 6:00 a.m. Oct. 30, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Where to Find Bargains Created by the Fed 8:12 p.m. Oct. 29, 2014 - TheStreet.com
Cramer's Lightning Round - Isis Pharmaceuticals Has The Best Pipeline (10/28/14) 6:59 a.m. Oct. 29, 2014 - Seeking Alpha
'Mad Money' Lightning Round: I'm Sticking With Isis Pharmaceuticals 6:00 a.m. Oct. 29, 2014 - TheStreet.com

Isis Pharmaceuticals to Present at Upcoming Investor Conferences 7:00 a.m. Nov. 14, 2014 - PR Newswire - PRF
AstraZeneca and Isis Pharmaceuticals to Co-Develop Targeted Oligonucleotide Delivery Methods 3:01 a.m. Nov. 13, 2014 - PR Newswire - PRF
Critical Alerts For Twitter, Isis Pharmaceuticals, TrueCar and Myriad Genetics Released By InvestorsObserver 9:31 a.m. Nov. 12, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Prices Offering of $425 Million of 1.00% Convertible Senior Notes 7:00 a.m. Nov. 12, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Announces Proposed Offering of $425 Million of Convertible Senior Notes 4:03 p.m. Nov. 10, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $10 Million Milestone Payment From Biogen Idec for Advancement of ISIS-BIIB3 Rx 7:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $7.5 Million Milestone Payment From AstraZeneca 7:00 a.m. Nov. 5, 2014 - PR Newswire - PRF
Regulus Announces Closing of Public Offering of $103.5M of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 4:05 p.m. Nov. 3, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $5 Million in Milestone Payment From GSK for Advancement of ISIS-GSK5 Rx 7:00 a.m. Nov. 3, 2014 - PR Newswire - PRF
Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 8:40 a.m. Oct. 31, 2014 - PR Newswire - PRF
Webcast Alert: Isis Pharmaceuticals' Third Quarter 2014 Financial Results Conference Call 7:00 a.m. Oct. 31, 2014 - PR Newswire - PRF
Critical Alerts For AT&T, SolarWinds, Whole Foods Market, FireEye and Isis Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Oct. 30, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Present at the Nomura Biotechnology Conference 7:00 a.m. Oct. 30, 2014 - PR Newswire - PRF
Regulus Announces Pricing of Public Offering of Common Stock 8:10 p.m. Oct. 28, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $18 Million From GSK for Advancing ISIS-TTR Rx 7:00 a.m. Oct. 9, 2014 - PR Newswire - PRF
Critical Alerts For petroleo brasileiro, Herbalife, Micron, FireEye and Isis Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Oct. 7, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Host Webcast to Discuss ISIS-SMN Rx Results Presented at the World Muscle Society Congress 7:00 a.m. Oct. 2, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $1.5 Million From GSK for the Advancement of ISIS-GSK4 Rx 7:00 a.m. Oct. 1, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Present at the Leerink Partners Rare Disease Roundtable 7:00 a.m. Sept. 24, 2014 - PR Newswire - PRF
Biotech Stocks in Motion - XOMA, Nanosphere, Isis Pharma, Halozyme Therapeutics, and Synta Pharma 8:45 a.m. Sept. 17, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Geolava, Vaidio, Sensoneo Triumph in Texas Pitch Contest

North Texas Lights the Innovation Torch Big moves are happening in North Texas, with a pitch competition that's more than just smoke and mirrors. We're talking about an arena where regional challenges meet cutting-edge solutions, and out of a global mix, Geolava, Vaidio, and Sensoneo snagged the 2026 North Texas Connected Innovation Pitch Contest crown. It's high stakes...

Lifeway Foods Set to Announce Q3 2026 Financial Results

Anticipating Lifeway Foods’ Q3 Results Dust off your calendars and mark November 12, 2026—because that's when Lifeway Foods is putting its cards on the table for the third quarter. Nothing like a results call to see if your investments are eating right. NASDAQ:LWAY is no stranger to making some noise in the dairy aisle, thanks to their kefir—that fermented probiotic...

Omaha Steaks Simplifies Gifting with Delicious Solutions

Who’s got time to fuss over the perfect holiday gift? Turns out, just about nobody. A recent survey suggests 79% of adults over 25 yearn to ditch the guessing games when it comes to gifting. Enter Omaha Steaks, staking its claim as the hero of culinary generosity. Eating Up the Holiday Stress This isn't just your average foodie fare. Omaha Steaks has cooked up a plan...

Digital Science's Game-Changing Jenni AI Acquisition

A Strategic Move in the Research Sector When you're dealing with tech giants and their endless race to corner niche markets, it's the big moves that really catch one's attention. The latest acquisition on the block is Digital Science picking up Jenni AI, a platform trusted by over 8 million students and researchers scattered across 189 countries. Now, that's a hefty user...

LG Energy Sparks Global Innovation with BIC 2026

Innovating Beyond Boundaries with LG Energy The world of battery tech is on fire, and LG Energy Solution is fanning the flames with their Battery Innovation Contest 2026 (BIC 2026). From October 29 to December 6, 2026, universities and research hives across the globe are being beckoned to pour their battery brilliance into this contest. These aren't just any research...

Collective Scoops $100M, Powers Solopreneur's Financial Might

Picture This: A Solo Businessman in 2026 Imagine a lone ranger running a show that used to take an entire office. That’s the magic happening with roughly 30 million solo businesses in the U.S. today, and folks, the numbers are staggering. As these one-man-bands push past clunky old systems, a big name is lighting the way: Collective. They raised a hefty $100 million to...

Digital Art Sparks Future City Visions in Beijing

Beijing's Bold Digital Art Venture: A New Era in Creativity Ever felt the jittery buzz of innovation on the cutting edge? That's exactly what visitors experienced in Beijing's 'Spiritual Land: Future World of Inspiration' exhibition at the BOE Yiyun Digital Art Center. Set against the backdrop of the sprawling metropolis, this joint effort between Beijing and Linz aims to...

McKay Brothers Enhances Fastest Routes for Market Data

Breaking Down McKay Brothers' Latest Maneuver Yeah, the financial market isn't just numbers and screens—it's about moving those numbers faster than a cheetah chasing prey. McKay Brothers knows this game inside and out, and they're laying down new wires, or rather, wireless, to make sure they've got the quickest routes in the room. Let me tell you, they're throwing money...

Hershey's Sweet Results: 2026 Earnings Soar

Hershey's 2026 Q3 Financial Performance: A Closer Look At the end of September, The Hershey Company (NYSE: HSY) dished out some eye-popping numbers for their third quarter. With a net sales increase of 3.0%, they clocked in at $3,275.5 million. More importantly, earnings per share-diluted shot up by a whopping 111.8%, landing at $2.88. Clearly, Hershey’s strategic moves...

New Insurance Rules Limit Public Input Amid Controversy

Insurance Rules Change the Game, Yet Again When the bureaucracy tightens its grip, consumers often pay the price. California's recent twist in insurance regulations does just that, taking a red pen to public involvement and paving the road for insurers to hike rates with less interference. A Peek Behind the Curtain This new maneuver by the Department of Insurance...